Trial intelligence / Profile preview

Vitamin D Supplementation to Increase Free Testosterone in Men With Type 2 Diabetes Mellitus

2018-001751-12Phase 2Active

Sponsor
UZ Brussel
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Hypogonadism comparing Vitamin D (BE461173) with Placebo (2 arms). Primary endpoints: Change in free testosterone concentration at 10 days and Change in free testosterone concentration at 3 months. Started Oct 2018; status: active.

02

Drugs

cholecalciferol
03

Conditions

type 2 diabetes mellitus (T2DM)Hypogonadism

Beyond the preview

Go deeper on 2018-001751-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001751-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call